New immunotherapy ‘highly effective’ against hepatitis B
Scientists at UCL have identified a new immunotherapy to combat the hepatitis B virus (HBV), the most common cause of liver cancer in the world.
- Next story Teens, adults who use E-cigarettes have increased odds of asthma, asthma attacks
- Previous story People at high genetic risk for colorectal cancer benefit more from lifestyle changes
Explore more
- Shame, Safety and Moving Beyond Cancel Culture
When is cancellation useful? And what other tools are available when it... - Selling a buffalo for a brain scan: India’s COVID-19 crisis reveals deep fractures in its health system
As India’s COVID-19 crisis continues, the percentage of the population testing positive... - Scientists develop mathematical model to calculate the daily rate of COVID-19 infections
According to their data, published in Scientific Reports, the number of people... - Prince of Persia: The Sands of Time Remake won’t be included at Ubisoft Forward event
Prince of Persia: The Sands of Time Remake won’t be included in... - Evolving, self-replicating robots are here — but don’t worry about an uprising
Self-replicating robots are a staple of apocalyptic science fiction movies, but now... - A Fragile Israeli Coalition, With Some Underlying Glue
An agreement to return to democratic norms might be the one thing... - Fatal Tesla crash in Texas appeared to have no driver
A Tesla Model S vehicle that crashed in Texas on Saturday, killing... - 100 days later, Brexit isn’t working and business wants it fixed
When British Prime Minister Boris Johnson announced his Brexit trade deal on... - Anthony Hopkins’ Oscar Win Ends Night Highlighted by Diversity
Six years after #OscarsSoWhite, a diverse roster of artists won awards, though... - Psychology research demonstrates unique ‘time compression’ effect of virtual reality
Grayson Mullen was playing a virtual reality game at a friend’s house...